HOOK – hookipa pharma inc. (US:NASDAQ)
Stock Stats
News
Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at HC Wainwright from $6.50 to $5.00. They now have a "buy" rating on the stock.
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab [Yahoo! Finance]
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday? [Yahoo! Finance]
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers [Yahoo! Finance]
Form ARS HOOKIPA Pharma Inc. For: Dec 31
Form DEFA14A HOOKIPA Pharma Inc.
Form DEF 14A HOOKIPA Pharma Inc. For: Jun 17
Form 8-K HOOKIPA Pharma Inc. For: Apr 25
Form 4 HOOKIPA Pharma Inc. For: Apr 15 Filed by: Kandera Reinhard
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.